You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RDHL Exercise Disclosure
Raday Gilead · SEC Form 4 · Filed Jul 13, 2026
Exercise
Calculated transaction value
$0
Raday Gilead Chief Operating Officer
RDHL
Transaction date
Jul 10, 2026
Public filing date
Jul 13, 2026
Filing lag
Filed 3 days later
RDHL daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- American Depositary Shares on Ordinary Shares
- Quantity / price
- 28,150,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001178913-26-003473
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$1.41K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Red Hill Biopharma Ltd. RDHL | Sale | Jul 10, 2026 | $1.41K |
| Red Hill Biopharma Ltd. RDHL Current | Exercise | Jul 10, 2026 | $0 |